AtriCure, Inc. Revenue
AtriCure, Inc. (ATRC) reported Revenue of $153.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-27
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $153.60M, a 12.83% increase year-over-year.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $141.25M, a 14.26% increase year-over-year.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $140.50M, a 13.05% increase year-over-year.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $134.27M, a 15.84% increase year-over-year.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $534.53M, a 14.88% increase from fiscal 2024.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $465.31M, a 16.55% increase from fiscal 2023.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $399.25M, a 20.84% increase from fiscal 2022.
- AtriCure, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $330.38M, a 20.43% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $153.60M 10-Q · filed 2026-07-27 | $294.85M 10-Q · filed 2026-07-27 | $435.35M derived: sum of 3 quarters · filed 2026-07-27 | $569.62M derived: sum of 4 quarters · filed 2026-07-27 |
| 2026-03-31 | $141.25M 10-Q · filed 2026-05-06 | $281.75M derived: sum of 2 quarters · filed 2026-05-06 | $416.02M derived: sum of 3 quarters · filed 2026-05-06 | $552.16M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-12-31 | $140.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $274.77M derived: sum of 2 quarters · filed 2026-02-19 | $410.91M derived: sum of 3 quarters · filed 2026-07-27 | $534.53M 10-K · filed 2026-02-19 |
| 2025-09-30 | $134.27M 10-Q · filed 2025-10-30 | $270.41M derived: sum of 2 quarters · filed 2026-07-27 | $394.03M 10-Q · filed 2025-10-30 | $518.30M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-06-30 | $136.14M 10-Q · filed 2026-07-27 | $259.76M 10-Q · filed 2026-07-27 | $384.04M derived: sum of 3 quarters · filed 2026-07-27 | $499.95M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-03-31 | $123.62M 10-Q · filed 2026-05-06 | $247.90M derived: sum of 2 quarters · filed 2026-05-06 | $363.81M derived: sum of 3 quarters · filed 2026-05-06 | $480.08M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $124.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $240.19M derived: sum of 2 quarters · filed 2026-02-19 | $356.46M derived: sum of 3 quarters · filed 2026-02-19 | $465.31M 10-K · filed 2026-02-19 |
| 2024-09-30 | $115.91M 10-Q · filed 2025-10-30 | $232.18M derived: sum of 2 quarters · filed 2025-10-30 | $341.03M 10-Q · filed 2025-10-30 | $447.57M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $116.27M 10-Q · filed 2025-07-30 | $225.12M 10-Q · filed 2025-07-30 | $331.66M derived: sum of 3 quarters · filed 2026-02-19 | $429.95M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $108.85M 10-Q · filed 2025-04-30 | $215.39M derived: sum of 2 quarters · filed 2026-02-19 | $313.68M derived: sum of 3 quarters · filed 2026-02-19 | $414.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $106.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $204.83M derived: sum of 2 quarters · filed 2026-02-19 | $305.75M derived: sum of 3 quarters · filed 2026-02-19 | $399.25M 10-K · filed 2026-02-19 |
| 2023-09-30 | $98.29M 10-Q · filed 2024-10-30 | $199.21M derived: sum of 2 quarters · filed 2024-10-30 | $292.70M 10-Q · filed 2024-10-30 | $380.73M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $100.92M 10-Q · filed 2024-07-31 | $194.41M 10-Q · filed 2024-07-31 | $282.44M derived: sum of 3 quarters · filed 2025-02-14 | $365.69M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $93.49M 10-Q · filed 2024-05-02 | $181.52M derived: sum of 2 quarters · filed 2025-02-14 | $264.77M derived: sum of 3 quarters · filed 2025-02-14 | $349.30M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $88.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $171.27M derived: sum of 2 quarters · filed 2025-02-14 | $255.80M derived: sum of 3 quarters · filed 2025-02-14 | $330.38M 10-K · filed 2025-02-14 |
| 2022-09-30 | $83.25M 10-Q · filed 2023-11-02 | $167.78M derived: sum of 2 quarters · filed 2023-11-02 | $242.35M 10-Q · filed 2023-11-02 | $315.57M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $84.53M 10-Q · filed 2023-07-26 | $159.10M 10-Q · filed 2023-07-26 | $232.32M derived: sum of 3 quarters · filed 2023-07-26 | $302.78M derived: sum of 4 quarters · filed 2023-07-26 |
| 2022-03-31 | $74.58M 10-Q · filed 2023-05-03 | $147.79M derived: sum of 2 quarters · filed 2023-05-03 | $218.25M derived: sum of 3 quarters · filed 2023-05-03 | $289.63M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $73.22M 10-Q · filed 2022-05-04 | $143.68M derived: sum of 2 quarters · filed 2022-11-02 | $215.05M derived: sum of 3 quarters · filed 2022-11-02 | $274.33M 10-K · filed 2024-02-16 |
| 2021-09-30 | $70.46M 10-Q · filed 2022-11-02 | $141.84M derived: sum of 2 quarters · filed 2022-11-02 | $201.11M 10-Q · filed 2022-11-02 | $258.84M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $71.38M 10-Q · filed 2022-08-03 | $130.65M 10-Q · filed 2022-08-03 | $188.38M derived: sum of 3 quarters · filed 2022-08-03 | $243.13M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $59.27M 10-Q · filed 2022-05-04 | $117.00M derived: sum of 2 quarters · filed 2022-05-04 | $171.76M derived: sum of 3 quarters · filed 2022-05-04 | $212.58M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $57.73M 10-K · filed 2021-02-26 | $112.48M derived: sum of 2 quarters · filed 2021-11-04 | $153.31M derived: sum of 3 quarters · filed 2021-11-04 | $206.53M 10-K · filed 2023-02-22 |
| 2020-09-30 | $54.76M 10-Q · filed 2021-11-04 | $95.58M derived: sum of 2 quarters · filed 2021-11-04 | $148.81M 10-Q · filed 2021-11-04 | $210.13M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $40.82M 10-Q · filed 2021-08-05 | $94.05M 10-Q · filed 2021-08-05 | $155.37M derived: sum of 3 quarters · filed 2021-08-05 | $211.98M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $53.23M 10-Q · filed 2021-04-28 | $114.55M derived: sum of 2 quarters · filed 2021-04-28 | $171.16M derived: sum of 3 quarters · filed 2021-04-28 | $230.07M derived: sum of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | $61.32M 10-K · filed 2021-02-26 | $117.94M derived: sum of 2 quarters · filed 2021-02-26 | $176.84M derived: sum of 3 quarters · filed 2021-02-26 | $230.81M 10-K · filed 2022-02-17 |
| 2019-09-30 | $56.61M 10-K · filed 2021-02-26 | $115.52M derived: sum of 2 quarters · filed 2021-02-26 | $169.49M 10-Q · filed 2020-11-06 | $222.38M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $58.91M 10-K · filed 2021-02-26 | $112.87M 10-Q · filed 2020-07-29 | $165.76M derived: sum of 3 quarters · filed 2021-02-26 | $215.71M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $53.97M 10-K · filed 2021-02-26 | $106.86M derived: sum of 2 quarters · filed 2021-02-26 | $156.80M derived: sum of 3 quarters · filed 2021-02-26 | $208.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $52.89M 10-K · filed 2020-02-24 | $102.83M derived: sum of 2 quarters · filed 2020-02-24 | $154.64M derived: sum of 3 quarters · filed 2020-02-24 | $201.63M 10-K · filed 2021-02-26 |
| 2018-09-30 | $49.94M 10-K · filed 2020-02-24 | $101.74M derived: sum of 2 quarters · filed 2020-02-24 | $148.74M 10-Q · filed 2019-10-31 | $194.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $51.80M 10-K · filed 2020-02-24 | $98.80M 10-Q · filed 2019-07-31 | $144.86M derived: sum of 3 quarters · filed 2020-02-24 | $187.01M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $46.99M 10-K · filed 2020-02-24 | $93.06M derived: sum of 2 quarters · filed 2020-02-24 | $135.21M derived: sum of 3 quarters · filed 2020-02-24 | |
| 2017-12-31 | $46.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $88.21M derived: sum of 2 quarters · filed 2020-02-24 | $174.72M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $42.15M 10-Q · filed 2018-11-02 | $128.65M 10-Q · filed 2018-11-02 | ||
| 2016-12-31 | $155.11M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |